Baseline characteristics from two ongoing phase III trials for the prevention and treatment of muscle wasting in NSCLC.
Publication
, Conference
Steiner, MS; Gralla, RJ; Prado, CMM; Hancock, ML; Dalton, JT; Johnston, MA; Crawford, J
Published in: JOURNAL OF CLINICAL ONCOLOGY
May 20, 2013
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2013
Volume
31
Issue
15
Location
Chicago, IL
Publisher
AMER SOC CLINICAL ONCOLOGY
Conference Name
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Steiner, M. S., Gralla, R. J., Prado, C. M. M., Hancock, M. L., Dalton, J. T., Johnston, M. A., & Crawford, J. (2013). Baseline characteristics from two ongoing phase III trials for the prevention and treatment of muscle wasting in NSCLC. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 31). Chicago, IL: AMER SOC CLINICAL ONCOLOGY.
Steiner, Mitchell S., Richard J. Gralla, Carla M. M. Prado, Michael L. Hancock, James T. Dalton, Mary Ann Johnston, and Jeffrey Crawford. “Baseline characteristics from two ongoing phase III trials for the prevention and treatment of muscle wasting in NSCLC.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 31. AMER SOC CLINICAL ONCOLOGY, 2013.
Steiner MS, Gralla RJ, Prado CMM, Hancock ML, Dalton JT, Johnston MA, et al. Baseline characteristics from two ongoing phase III trials for the prevention and treatment of muscle wasting in NSCLC. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2013.
Steiner, Mitchell S., et al. “Baseline characteristics from two ongoing phase III trials for the prevention and treatment of muscle wasting in NSCLC.” JOURNAL OF CLINICAL ONCOLOGY, vol. 31, no. 15, AMER SOC CLINICAL ONCOLOGY, 2013.
Steiner MS, Gralla RJ, Prado CMM, Hancock ML, Dalton JT, Johnston MA, Crawford J. Baseline characteristics from two ongoing phase III trials for the prevention and treatment of muscle wasting in NSCLC. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2013.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2013
Volume
31
Issue
15
Location
Chicago, IL
Publisher
AMER SOC CLINICAL ONCOLOGY
Conference Name
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences